Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

MedCare opens new U.S. treatment centers for urinary incontinence

Jan. 10, 1997

Positive phase III trial results reported for phosphate binder

Jan. 9, 1997

P&U files for European approval of urinary incontinence Rx

Jan. 9, 1997

Watson's first NDA product approved

Jan. 3, 1997

Anti-TGF-beta MAbs from Celtrix

Dec. 31, 1996

LJP licenses rights to drug for lupus

Dec. 30, 1996

Nonsteroidal 5alpha-reductase inhibitors reported by Kyowa Hakko

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

Licensees sought for PKD1 gene and mutations

Dec. 17, 1996

More terazosin clinical data reported

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...